QQQ   311.29 (+3.45%)
AAPL   149.98 (+3.13%)
MSFT   261.35 (+3.40%)
META   192.59 (+25.78%)
GOOGL   106.50 (+6.04%)
AMZN   112.46 (+6.95%)
TSLA   194.49 (+7.21%)
NVDA   216.60 (+3.42%)
NIO   12.14 (+0.33%)
BABA   108.43 (-3.89%)
AMD   88.09 (+4.08%)
T   20.41 (+1.14%)
MU   63.29 (+1.10%)
F   14.48 (+5.00%)
CGC   3.14 (+1.95%)
GE   83.33 (+1.23%)
DIS   112.60 (+2.93%)
AMC   6.29 (+10.16%)
PFE   44.22 (+0.57%)
PYPL   88.33 (+6.54%)
NFLX   365.71 (+1.03%)
QQQ   311.29 (+3.45%)
AAPL   149.98 (+3.13%)
MSFT   261.35 (+3.40%)
META   192.59 (+25.78%)
GOOGL   106.50 (+6.04%)
AMZN   112.46 (+6.95%)
TSLA   194.49 (+7.21%)
NVDA   216.60 (+3.42%)
NIO   12.14 (+0.33%)
BABA   108.43 (-3.89%)
AMD   88.09 (+4.08%)
T   20.41 (+1.14%)
MU   63.29 (+1.10%)
F   14.48 (+5.00%)
CGC   3.14 (+1.95%)
GE   83.33 (+1.23%)
DIS   112.60 (+2.93%)
AMC   6.29 (+10.16%)
PFE   44.22 (+0.57%)
PYPL   88.33 (+6.54%)
NFLX   365.71 (+1.03%)
QQQ   311.29 (+3.45%)
AAPL   149.98 (+3.13%)
MSFT   261.35 (+3.40%)
META   192.59 (+25.78%)
GOOGL   106.50 (+6.04%)
AMZN   112.46 (+6.95%)
TSLA   194.49 (+7.21%)
NVDA   216.60 (+3.42%)
NIO   12.14 (+0.33%)
BABA   108.43 (-3.89%)
AMD   88.09 (+4.08%)
T   20.41 (+1.14%)
MU   63.29 (+1.10%)
F   14.48 (+5.00%)
CGC   3.14 (+1.95%)
GE   83.33 (+1.23%)
DIS   112.60 (+2.93%)
AMC   6.29 (+10.16%)
PFE   44.22 (+0.57%)
PYPL   88.33 (+6.54%)
NFLX   365.71 (+1.03%)
QQQ   311.29 (+3.45%)
AAPL   149.98 (+3.13%)
MSFT   261.35 (+3.40%)
META   192.59 (+25.78%)
GOOGL   106.50 (+6.04%)
AMZN   112.46 (+6.95%)
TSLA   194.49 (+7.21%)
NVDA   216.60 (+3.42%)
NIO   12.14 (+0.33%)
BABA   108.43 (-3.89%)
AMD   88.09 (+4.08%)
T   20.41 (+1.14%)
MU   63.29 (+1.10%)
F   14.48 (+5.00%)
CGC   3.14 (+1.95%)
GE   83.33 (+1.23%)
DIS   112.60 (+2.93%)
AMC   6.29 (+10.16%)
PFE   44.22 (+0.57%)
PYPL   88.33 (+6.54%)
NFLX   365.71 (+1.03%)
NASDAQ:MLAB

Mesa Laboratories - MLAB Stock Forecast, Price & News

$204.41
+8.11 (+4.13%)
(As of 02/2/2023 12:49 PM ET)
Add
Compare
Today's Range
$196.22
$205.40
50-Day Range
$161.65
$202.26
52-Week Range
$114.21
$279.60
Volume
49,500 shs
Average Volume
81,509 shs
Market Capitalization
$1.09 billion
P/E Ratio
N/A
Dividend Yield
0.33%
Price Target
$166.00

Mesa Laboratories MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
18.3% Downside
$166.00 Price Target
Short Interest
Bearish
8.49% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.76mentions of Mesa Laboratories in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$1.22 M Sold Last Quarter
Proj. Earnings Growth
1.99%
From $6.52 to $6.65 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.91 out of 5 stars

Medical Sector

1024th out of 1,030 stocks

Process Control Instruments Industry

11th out of 11 stocks


MLAB stock logo

About Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Stock News Headlines

Is Mesa Laboratories (MLAB) a Growing Stock?
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Bull of the Day: Mesa Labs (MLAB)
Here’s Why Mesa Laboratories (MLAB) Declined in Q3
Why Mesa Laboratories (MLAB) Stock Is Getting Hammered Today
Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates
MLAB Mesa Laboratories, Inc.
See More Headlines
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Company Calendar

Last Earnings
5/31/2021
Ex-Dividend for 12/15 Dividend
11/29/2022
Dividend Payable
12/15/2022
Today
2/02/2023
Next Earnings (Confirmed)
2/06/2023
Ex-Dividend for 3/15 Dividend
2/27/2023
Dividend Payable
3/15/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Process control instruments
Sub-Industry
Electronic Equipment & Instruments
Sector
Medical
Current Symbol
NASDAQ:MLAB
CUSIP
59064R10
Employees
506
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$166.00
High Stock Price Forecast
$166.00
Low Stock Price Forecast
$166.00
Forecasted Upside/Downside
-18.8%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$1.87 million
Pretax Margin
-1.98%

Debt

Sales & Book Value

Annual Sales
$184.34 million
Cash Flow
$11.82 per share
Book Value
$75.07 per share

Miscellaneous

Free Float
5,043,000
Market Cap
$1.09 billion
Optionable
Not Optionable
Beta
0.70

Key Executives

  • John James Sullivan
    Chairman
  • Gary M. OwensGary M. Owens
    President, CEO, COO & Director
  • John V. SakysJohn V. Sakys
    CFO, Treasurer & Chief Accounting Officer
  • Peter Jung
    Vice President-Strategy & Corporate Development
  • Brian Archbold
    Senior Vice President-Continuous Improvement













MLAB Stock - Frequently Asked Questions

What is Mesa Laboratories' stock price forecast for 2023?

0 Wall Street analysts have issued 12 month price targets for Mesa Laboratories' shares. Their MLAB share price forecasts range from $166.00 to $166.00. On average, they anticipate the company's share price to reach $166.00 in the next year. This suggests that the stock has a possible downside of 17.3%.
View analysts price targets for MLAB
or view top-rated stocks among Wall Street analysts.

How have MLAB shares performed in 2023?

Mesa Laboratories' stock was trading at $166.21 at the beginning of the year. Since then, MLAB shares have increased by 20.8% and is now trading at $200.74.
View the best growth stocks for 2023 here
.

When is Mesa Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023.
View our MLAB earnings forecast
.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) released its earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.91 by $0.17. The medical instruments supplier had revenue of $37.96 million for the quarter, compared to analysts' expectations of $34.92 million. Mesa Laboratories had a negative net margin of 1.78% and a positive trailing twelve-month return on equity of 6.71%.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, January 3rd. Investors of record on Tuesday, February 28th will be paid a dividend of $0.16 per share on Wednesday, March 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Monday, February 27th.
Read our dividend analysis for MLAB
.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.33%.
Read our dividend analysis for MLAB.

What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (10.76%), Comerica Bank (0.94%), Rice Hall James & Associates LLC (0.27%), Moody Aldrich Partners LLC (0.21%), Yousif Capital Management LLC (0.06%) and Exchange Traded Concepts LLC (0.06%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys, Robert V Dwyer and Shannon Hall.
View institutional ownership trends
.

How do I buy shares of Mesa Laboratories?

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $200.74.

How much money does Mesa Laboratories make?

Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $1.07 billion and generates $184.34 million in revenue each year. The medical instruments supplier earns $1.87 million in net income (profit) each year or ($0.76) on an earnings per share basis.

How many employees does Mesa Laboratories have?

The company employs 506 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989.

This page (NASDAQ:MLAB) was last updated on 2/2/2023 by MarketBeat.com Staff